Kuros Biosciences Announces Management Succession
(WorldNews Health)

Kuros announced today the appointment of Michael Grau as Chief Financial Officer (CFO) effective February 1, 2018. Michael Grau succeeds Harry Welten, who will step down as CFO on February 1, 2018 to focus on his board roles and part-time CFO functions in privately held companies. Harry Welten will remain on the Board of Directors of Kuros. Kuros` Chief Executive Officer Dr. Joost de Bruijn commented: `I am delighted to welcome Michael Grau to the executive team. Michael has extensive experience in...